Warnings and precautions for using efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, Viraday)

Use efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, span>Viraday) When treating HIV infection, patients should pay attention to the following warnings and precautions to ensure the safe and effective use of the drug:

1. Use only under the guidance of a physician: Efavirenz/Emtricitabine/Tenofovir is a prescription drug that should be prescribed and supervised by an experienced HIV treatment specialist or physician. Patients should not adjust the dosage or stop using efavirenz/emtricitabine/tenofovir/tenofovir on their own and should strictly follow the doctor's treatment plan.

2. Liver function monitoring: During the use ofefavirenz/emtricitabine/tenofovir, the patient's liver function should be monitored regularly. Efavirenz/Emtricitabine/Tenofovir may cause mild liver function abnormalities, so doctors will adjust treatment plans based on test results.

3. Alcohol and drug abuse: Patients should avoid alcohol and drug abuse when using EFV. Alcohol and certain drugs may interact with EFV, affecting the efficacy and safety of the drugs.

4. High alertness task: When first starting to useefavirenz/emtricitabine/tenofovir, EFV may cause some patients to feel dizzy, drowsy or mentally unstable. In this case, the patient should avoid tasks that require a high degree of alertness, such as driving a motor vehicle or operating machinery.

5. Drug interactions: Useefavirenz/Emtricitabine/TenofovirYou should inform your doctor of other drugs you are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with efavirenz/emtricitabine/tenofovir, affecting the efficacy and safety of the drugs.

6. Pregnant and lactating women: Women who are pregnant or planning to become pregnant should use efavirenz/emtricitabine/tenofovir under the guidance of a doctor. The use of efavirenz/emtricitabine/tenofovir during pregnancy may need to be evaluated on a patient-specific basis. Efavirenz is not recommended for breastfeeding women because the drug may be passed to the baby through breast milk.

7. Resistance: Efavirenz/Emtricitabine/TenofovirAs a compound antiretroviral therapy, patients should strictly follow the treatment plan and avoid missing medications to reduce the risk of drug resistance. If a patient experiences poor efficacy or rebound in viral load while taking efavirenz/emtricitabine/tenofovir, they should report to their doctor in a timely manner for further evaluation and management.

8. Medications for special groups: Efavirenz/Emtricitabine/Tenofovir is not suitable for children younger than 12 years old or weighing less than 40kg. For patients with abnormal renal function or liver function, especially those with impaired renal function, efavirenz should be used with caution/emtricitabine/tenofovir.

The above warnings and precautions are intended to help patients use efavirenz/emtricitabine/tenofovir (Viraday) safely and effectively for their HIV treatment. During the period of using Viraday, patients should pay close attention to their physical condition, receive regular monitoring and guidance from their doctors, and promptly report any discomfort and side effects to their doctors for timely adjustment and management.

Efavirenz/Emtricitabine/Tenofovir (EFV+FTC+TDF, Efavire Emtricitabine/Tenofovir) is not currently on the market in China, so patients cannot purchase it domestically and need to purchase it through overseas purchasing channels. The cheaper ones abroad are mainly Indian generic drugs, which cost around 380 yuan.